Skip to main content

Boehringer Ingelheim Pharmaceuticals, Inc.

Recalls

Recalls by year

A bar chart of the number of recalls naming this company by year.

Recalls by year
YearRecalls
20162
20171
20183
20191
20203
20211
20231
20261
Download CSV

FDA Recall Terminated Historical recordClass II

Persantine (dipyridamole USP) tablets, 75 mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877, NDC 0597-0019-01

by Boehringer Ingelheim Pharmaceuticals, Inc.

Reason
Presence of foreign tablets/capsules: 50 mg Persantine tablets were found in a 75 mg Persantine 100-count bottle and 50 mg Persantine tablet was found in a 100 count bottle of 75 mg Dipyridamole.
Published
November 2, 2016
Distribution
Nationwide

View recall →

This page lists recalls that name Boehringer Ingelheim Pharmaceuticals, Inc. as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.